R. Fuhrhop

发表

Conquering the dark side: colloidal iron oxide nanoparticles.

S. Caruthers, D. Pan, G. Hu, 2009, ACS nano.

Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles

Samuel A. Wickline, Patrick M. Winter, Shelton D. Caruthers, 2003 .

Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Shelton D Caruthers, Samuel A Wickline, Gregory M Lanza, 2003, Circulation.

Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI

Shelton D Caruthers, Samuel A Wickline, Gregory M Lanza, 2004, Magnetic resonance in medicine.

Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology.

P. Winter, S. Wickline, G. Lanza, 2002, Academic radiology.

Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent.

J. Allen, S. Wickline, G. Lanza, 2002, Academic radiology.

Comparison of ultrasound scattering behavior of Optison/sup /spl reg// and a liquid perfluorocarbon nanoparticle contrast agent

S. Wickline, G. Lanza, R. Fuhrhop, 2002, 2002 IEEE Ultrasonics Symposium, 2002. Proceedings..

Molecular imaging using a site-targeted ultrasound contrast agent

S. Wickline, G. Lanza, M. Scott, 1999, 1999 IEEE Ultrasonics Symposium. Proceedings. International Symposium (Cat. No.99CH37027).

Experimental determination of phase velocity of perfluorocarbons: Applications to targeted contrast agents

J. H. Rose, S. Wickline, G. Lanza, 2000, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With (cid:1) v (cid:2) 3 -Integrin–Targeted Nanoparticles

S. Caruthers, P. Winter, J. D. Robertson, 2003 .

Improved Paramagnetic Chelate for Molecular Imaging with MRI

P. Winter, J. D. Robertson, S. Wickline, 2005 .

Abstract 1162: avb3-Integrin-targeted Paramagnetic Nanoparticles Deliver Rapamycin into the Vascular Wall and Inhibit Stenosis Following Balloon Injury

S. Caruthers, T. Harris, T. Williams, 2006 .

1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles

S. Caruthers, P. Winter, T. Harris, 2004 .

Augmented and selective delivery of liquid perfluorocarbon nanoparticles to melanoma cells with noncavitational ultrasound

S. Wickline, G. Lanza, M. Scott, 2003, IEEE Symposium on Ultrasonics, 2003.

Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis

Kerry K. Karukstis, Lori K. Chinen, Samuel A. Wickline, 2002, Circulation.

Application of Renyi Entropy to Detect Subtle Changes in Scattering Architecture

J. McCarthy, J. Arbeit, S. Wickline, 2008 .

Targeted acoustic contrast agents: New opportunities for ultrasound in medical diagnosis and therapy

J. H. Rose, S. Wickline, G. Lanza, 1998 .

Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles.

Xin Cai, Samuel Achilefu, Chulhong Kim, 2011, ACS nano.

Molecular Imaging of Human Thrombus with Computed Tomography

Himanshu P. Shukla, Patrick J. Gaffney, Samuel A. Wickline, 2005 .

Synthesis of heterocyclic compounds from o-aminobenzenethiol and ammonium thiocarbamate

R. Fuhrhop, J. J. D'amico, W. E. Dahl, 1986 .

Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model

S. Wickline, G. Lanza, P. Gaffney, 2002, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles.

Samuel Achilefu, Walter J Akers, Samuel A Wickline, 2010, Nanomedicine.

Ultrasonic molecular imaging of primordial angiogenic vessels in rabbit and mouse models with /spl alpha//sub v//spl beta//sub 3/ -integrin targeted nanoparticles using information-theoretic signal detection: results at high frequency and in the clinical diagnostic frequency range

J. Arbeit, S. Wickline, G. Lanza, 2005, IEEE Ultrasonics Symposium, 2005..

Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.

Samuel A Wickline, Gregory M Lanza, S. Wickline, 2005, Ultrasound in medicine & biology.

Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents

Kendall R. Waters, S. A. Wickline, Gregory M. Lanza, 1997, 1997 IEEE Ultrasonics Symposium Proceedings. An International Symposium (Cat. No.97CH36118).

Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.

Samuel A Wickline, Gregory M Lanza, Patrick M Winter, 2004, Magnetic resonance in medicine.

Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging.

Samuel A Wickline, Gregory M Lanza, Christopher S Hall, 2005, The Journal of the Acoustical Society of America.

Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.

Shelton D Caruthers, Samuel A Wickline, Gregory M Lanza, 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

Application of Renyi entropy for ultrasonic molecular imaging.

S A Wickline, L Thomas, J. McCarthy, 2009, The Journal of the Acoustical Society of America.